347 related articles for article (PubMed ID: 23791669)
21. Comparision of secretagogue effects of rosiglitazone and telmisartan on ANP secretion in rats.
Gao S; Park BM; Cha SA; Kim SZ; Kim SH
Peptides; 2014 Jun; 56():52-8. PubMed ID: 24703963
[TBL] [Abstract][Full Text] [Related]
22. Atrial secretion of ANP is suppressed in renovascular hypertension: shifting of ANP secretion from atria to the left ventricle.
Tan R; Ahn YM; Kim HY; Lee YJ; Cho KW; Kang DG; Lee HS
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H590-H601. PubMed ID: 29979625
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway.
Hakam AC; Hussain T
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1430-6. PubMed ID: 16380464
[TBL] [Abstract][Full Text] [Related]
24. Reversal of fructose-induced hypertension and insulin resistance by chronic losartan treatment is independent of AT2 receptor activation in rats.
Hsieh PS
J Hypertens; 2005 Dec; 23(12):2209-17. PubMed ID: 16269963
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
Brouwers S; Smolders I; Massie A; Dupont AG
Hypertension; 2013 Nov; 62(5):920-6. PubMed ID: 24041944
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y
J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361
[TBL] [Abstract][Full Text] [Related]
27. Attenuation of hypoosmotic stress-induced ANP secretion via I(Cl,swell) in renal hypertensive rat atria.
Bai GY; Yuan K; Park WH; Kim SZ; Kim SH
Peptides; 2008 Sep; 29(9):1566-74. PubMed ID: 18582990
[TBL] [Abstract][Full Text] [Related]
28. Dynamic expression of the angiotensin II type 2 receptor and duodenal mucosal alkaline secretion in the Sprague-Dawley rat.
Ewert S; Sjoberg T; Johansson B; Duvetorp A; Holm M; Fandriks L
Exp Physiol; 2006 Jan; 91(1):191-9. PubMed ID: 16263801
[TBL] [Abstract][Full Text] [Related]
29. Role of Mas receptor antagonist (A779) on pressure diuresis and natriuresis and renal blood flow in the absence of angiotensin II receptors type 1 and 2 in female and male rats.
Mansoori A; Oryan S; Nematbakhsh M
J Physiol Pharmacol; 2014 Oct; 65(5):633-9. PubMed ID: 25371522
[TBL] [Abstract][Full Text] [Related]
30. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.
Kumar R; Cartledge WA; Lincoln TM; Pandey KN
Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II type 2 receptor-dependent increase in nitric oxide synthase activity in the endothelium of db/db mice is mediated via a MEK pathway.
Taguchi K; Matsumoto T; Kamata K; Kobayashi T
Pharmacol Res; 2012 Jul; 66(1):41-50. PubMed ID: 22465219
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin AT2 receptor mediated inhibition of particulate guanylate cyclase: a link with protein tyrosine phosphatase stimulation?
Brechler V; Levens NR; De Gasparo M; Bottari SP
Recept Channels; 1994; 2(2):79-87. PubMed ID: 7525002
[TBL] [Abstract][Full Text] [Related]
33. Comparative effects of angiotensin II and angiotensin-(4-8) on blood pressure and ANP secretion in rats.
Phuong HTA; Yu L; Park BM; Kim SH
Korean J Physiol Pharmacol; 2017 Nov; 21(6):667-674. PubMed ID: 29200910
[TBL] [Abstract][Full Text] [Related]
34. Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension.
Bae EH; Ma SK; Lee J; Kim SW
Regul Pept; 2011 Oct; 170(1-3):31-7. PubMed ID: 21616096
[TBL] [Abstract][Full Text] [Related]
35. Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.
Crassous PA; Couloubaly S; Huang C; Zhou Z; Baskaran P; Kim DD; Papapetropoulos A; Fioramonti X; Durán WN; Beuve A
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H597-604. PubMed ID: 22730391
[TBL] [Abstract][Full Text] [Related]
36. Modification of levosimendan-induced suppression of atrial natriuretic peptide secretion in hypertrophied rat atria.
Yu L; Yuan K; Park BM; Kim SH
Eur J Pharmacol; 2018 Jun; 829():54-62. PubMed ID: 29653089
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II Type 2 Receptor and Receptor Mas Are Colocalized and Functionally Interdependent in Obese Zucker Rat Kidney.
Patel SN; Ali Q; Samuel P; Steckelings UM; Hussain T
Hypertension; 2017 Oct; 70(4):831-838. PubMed ID: 28827476
[TBL] [Abstract][Full Text] [Related]
38. Modification of atrial natriuretic peptide system in cold-induced hypertensive rats.
Yuan K; Jin X; Park WH; Kim JH; Park BH; Kim SH
Regul Pept; 2009 Apr; 154(1-3):112-20. PubMed ID: 19254746
[TBL] [Abstract][Full Text] [Related]
39. Essential roles of the nitric oxide (no)/cGMP/protein kinase G type-Iα (PKG-Iα) signaling pathway and the atrial natriuretic peptide (ANP)/cGMP/PKG-Iα autocrine loop in promoting proliferation and cell survival of OP9 bone marrow stromal cells.
Wong JC; Fiscus RR
J Cell Biochem; 2011 Mar; 112(3):829-39. PubMed ID: 21328456
[TBL] [Abstract][Full Text] [Related]
40. Role of nitric oxide on atrial natriuretic peptide release induced by angiotensin II in superfused rat atrial tissue.
Soualmia H; Barthélemy C; Eurin J; Masson F; Carayon A
Regul Pept; 2001 Apr; 98(3):105-10. PubMed ID: 11231039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
